Clinical Study
Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia
Table 3
Adverse events in pediatric patients with iron deficiency anemia receiving oral iron therapy with iron hydroxide polymaltose complex (IPC) or ferrous sulfate, n (%).
| |||||||||||||||||||||||||||||||||||||